depressive disorder, major
Showing 26 - 50 of 302
Major Depressive Disorder Who Have HadInadequate Response
Terminated
- Depressive Disorder, Major
- Standard of Care (SOC)
-
San Francisco, California
- +3 more
Dec 6, 2022
Depressive Disorder, Major, Treatment Resistant Depression, Melancholia Trial in Ghent (device, behavioral, drug)
Recruiting
- Depressive Disorder, Major
- +2 more
- aiTBS
- +2 more
-
Ghent, East-Flanders, BelgiumUniversity Hospital Ghent
Dec 6, 2022
Electroconvulsive Therapy
Not yet recruiting
- Depressive Disorder, Major
- Electroconvulsive therapy
- (no location specified)
Nov 18, 2022
Depressive Disorder, Major, Treatment Outcome, Cognitive Dysfunction Trial in Copenhagen (Treatment Package for First-Episode
Recruiting
- Depressive Disorder, Major
- +4 more
- Treatment Package for First-Episode Depression
-
Copenhagen, DenmarkNeurobiology Research Unit, Rigshospitalet
Nov 12, 2022
Depressive Disorder, Major, Anxiety Disorder Trial (Nociceptin Receptor Antagonist, Aversive stimuli)
Not yet recruiting
- Depressive Disorder, Major
- Anxiety Disorder
- Nociceptin Receptor Antagonist
- Aversive stimuli
- (no location specified)
Nov 3, 2022
Depressive Disorder, Major, Inflammation Trial in Amsterdam (Celecoxib 400mg, Placebo)
Recruiting
- Depressive Disorder, Major
- Inflammation
- Celecoxib 400mg
- Placebo
-
Amsterdam, NetherlandsDepartment of Psychiatry Amsterdam UMC
Sep 28, 2022
Depressive Disorder, Major Trial in United States (Esketamine, Aripiprazole)
Not yet recruiting
- Depressive Disorder, Major
-
Tuscaloosa, Alabama
- +26 more
Sep 21, 2022
Spinal Cord Injuries, Depression, Depressive Disorder, Major Trial in Charleston (repetitive transcranial magnetic stimulation)
Not yet recruiting
- Spinal Cord Injuries
- +2 more
- repetitive transcranial magnetic stimulation
-
Charleston, South CarolinaRalph H. Johnson VA Medical Center, Charleston, SC
Sep 20, 2022
Depressive Disorder, Major Trial in Worldwide (Vortioxetine 10 mg/day, Vortioxetine 20 mg/day, Fluoxetine 20mg/day)
Completed
- Depressive Disorder, Major
- Vortioxetine 10 mg/day
- +3 more
-
Little Rock, Arkansas
- +97 more
Aug 29, 2022
General Psychopathology, Fatigue, Depressive Disorder, Major Trial in Münsterlingen (Integrated 5-day Gratitude Exercise and
Recruiting
- General Psychopathology
- +2 more
- Integrated 5-day Gratitude Exercise and Behavioral Activation Program
-
Münsterlingen, Thurgau, SwitzerlandPsychiatric Service Thurgau
Sep 15, 2022
Depressive Disorder, Major Trial in Worldwide (Esketamine 28 mg, Esketamine 56 mg, Esketamine 84 mg)
Completed
- Depressive Disorder, Major
- Esketamine 28 mg
- +6 more
-
Ciudad Autonoma de Buenos Aires, Argentina
- +170 more
Sep 13, 2022
Depression, Depressive Disorder, Depressive Disorder, Major Trial in France (microbiotherapy (GynMDD), )
Recruiting
- Depression
- +2 more
- microbiotherapy (GynMDD)
- placebo
-
Besançon, France
- +3 more
Sep 8, 2022
Depressive Disorder, Major Trial in Worldwide (BI 1358894, Placebo, Quetiapine)
Recruiting
- Depressive Disorder, Major
- BI 1358894
- +2 more
-
Birmingham, Alabama
- +83 more
Aug 22, 2022
Depressive Disorder, Major Trial in Alken, Aachen (Seltorexant Dose 1, Seltorexant Dose 2, Placebo)
Recruiting
- Depressive Disorder, Major
- Seltorexant Dose 1
- +3 more
-
Alken, Belgium
- +1 more
Aug 17, 2022
Depressive Disorder, Major Trial in Worldwide (Intranasal Placebo, Midazolam Placebo Solution, Midazolam)
Recruiting
- Depressive Disorder, Major
- Intranasal Placebo
- +3 more
-
Panorama City, California
- +65 more
Aug 17, 2022
Depressive Disorder, Major Trial in Worldwide (Seltorexant, Placebo)
Recruiting
- Depressive Disorder, Major
- Seltorexant
- Placebo
-
San Diego, California
- +26 more
Aug 17, 2022
Digital Care Chains in Health Care -Study of Care Consumption,
Active, not recruiting
- Depression
- +4 more
- Digital healthcare platform
-
Gävle, Gävleborg, SwedenCounty of Gavleborg
Aug 16, 2022
Depressive Disorder, Major Trial in United States (JNJ-42847922, Placebo Matching to JNJ-42847922, Quetiapine XR)
Depressive Disorder, Major, Bipolar Disorder, Post Traumatic Stress Disorder Trial in New Haven (Ketamine, Perampanel, Placebo)
Recruiting
- Depressive Disorder, Major
- +2 more
- Ketamine
- +2 more
-
New Haven, ConnecticutYale University
Aug 8, 2022
Pharmacogenetics, Depressive Disorder, Major, Medication Therapy Management Trial in Tuscaloosa (Pharmacogenomic Screening)
Withdrawn
- Pharmacogenetics
- +2 more
- Pharmacogenomic Screening
-
Tuscaloosa, AlabamaTuscaloosa VAMC
Aug 8, 2022
Schizophrenia, Bipolar Disorder, Depressive Disorder, Major Trial in Minneapolis (Social Cognition and Interaction Training-Work
Not yet recruiting
- Schizophrenia
- +3 more
- Social Cognition and Interaction Training-Work Edition (SCIT-WE)
-
Minneapolis, MinnesotaMinneapolis VA Health Care System, Minneapolis, MN
Aug 4, 2022
Stress Disorders, Post-Traumatic, Depressive Disorder, Major, Anxiety Disorder Trial in Marseille, Montpellier, Tours (Clinical,
Not yet recruiting
- Stress Disorders, Post-Traumatic
- +2 more
- Clinical, cognitive and biological tests
-
Marseille, France
- +3 more
Aug 4, 2022